| Literature DB >> 34634682 |
André Diedrich1, Vasile Urechie2, Dana Shiffer3, Stefano Rigo4, Maura Minonzio3, Beatrice Cairo5, Emily C Smith2, Luis E Okamoto2, Franca Barbic6, Andrea Bisoglio4, Alberto Porta5, Italo Biaggioni2, Raffaello Furlan6.
Abstract
Postural Tachycardia Syndrome (POTS) is a chronic disorder characterized by symptoms of orthostatic intolerance such as fatigue, lightheadedness, dizziness, palpitations, dyspnea, chest discomfort and remarkable tachycardia upon standing. Non-invasive transdermal vagal stimulators have been applied for the treatment of epilepsy, anxiety, depression, headache, and chronic pain syndromes. Anti-inflammatory and immunomodulating effects after transdermal vagal stimulation raised interest for applications in other diseases. Patients with sympathetic overactivity, reduced cardiac vagal drive and presence of systemic inflammation like POTS may benefit from tVNS. This article will address crucial methodological aspects of tVNS and provide preliminary results of its acute and chronic use in POTS, with regards to its potential effectiveness on autonomic symptoms reduction and heart rate modulation.Entities:
Keywords: Autonomic function; Postural tachycardia syndrome; Vagal stimulation
Mesh:
Year: 2021 PMID: 34634682 PMCID: PMC8939715 DOI: 10.1016/j.autneu.2021.102886
Source DB: PubMed Journal: Auton Neurosci ISSN: 1566-0702 Impact factor: 3.145